Impaired Fibrinolysis in Angiographically Documented Coronary Artery Disease

Table 2

Plasma fibrinolytic markers.

	Group I	Groups II/III	Group IV
	35	31	57	—
PAI-1	34.90 (27.86; 42.43)	40.50 (34.24; 51.83)	66.60^a,b(44.70; 91.65)
TAFI	5.71 ± 1.73	5.21 ± 1.42	4.97 ± 1.41	ns

= sample size; Group I = normal; Groups II/III = mild/moderate atheromatosis, up to 70% in at least one coronary artery; Group IV = severe atheromatosis, >70% in at least one coronary artery; PAI-1 = type 1 plasminogen activator inhibitor; TAFI = thrombin activatable fibrinolysis inhibitor; versus Group I and ^bversus Groups II/III; ns = not significant.
Values for PAI-1 are given in median (25th and 75th percentiles) and expressed in (ng/mL).
Values for TAFI are given in mean ± SD and expressed in (g/mL).